<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Traceable Drug Recommendation over Medical Knowledge Graphs - Health AI Hub</title>
    <meta name="description" content="This paper introduces TraceDR, a novel drug recommendation system built on a medical knowledge graph (MKG) that addresses the critical lack of traceability in e">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Traceable Drug Recommendation over Medical Knowledge Graphs</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27274v1" target="_blank">2510.27274v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yu Lin, Zhen Jia, Philipp Christmann, Xu Zhang, Shengdong Du, Tianrui Li
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.IR, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27274v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27274v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces TraceDR, a novel drug recommendation system built on a medical knowledge graph (MKG) that addresses the critical lack of traceability in existing deep learning approaches. Through a multi-task learning framework, TraceDR simultaneously predicts drug recommendations and their supporting evidence, enhancing transparency and trust in high-stakes clinical applications. The authors also release DrugRec, a new large-scale testbed constructed via an automated patient health record generation framework, to support more diverse disease and drug coverage.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for patient safety and clinician trust in AI-driven healthcare, as it provides explainable rationales for drug recommendations in a high-stakes domain where opaque 'black box' decisions are unacceptable. Traceable recommendations can mitigate risks of medication errors and facilitate informed clinical decision-making.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper proposes 'TraceDR', a novel AI-powered Drug Recommendation system that leverages deep learning over medical knowledge graphs to suggest medications and provide traceable evidence for these recommendations, thereby serving as a critical tool for clinical decision support.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical limitation of non-traceable recommendations in state-of-the-art deep learning-based drug recommendation (DR) systems.</li>
                    
                    <li>Proposes TraceDR, a novel DR system leveraging a medical knowledge graph (MKG) for comprehensive and high-quality information access.</li>
                    
                    <li>Employs a multi-task learning framework to simultaneously predict drug recommendations and their underlying evidence, ensuring traceability.</li>
                    
                    <li>Devises a framework for automatically constructing diverse patient health records to cover a broader spectrum of diseases and drugs than previous works.</li>
                    
                    <li>Releases DrugRec, a new large-scale testbed specifically designed for advancing drug recommendation research.</li>
                    
                    <li>Aims to improve the reliability, safety, and adoption of AI in healthcare by providing transparent, evidence-backed medication suggestions.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>TraceDR operates over a medical knowledge graph (MKG) to access vast amounts of medical information. It utilizes a multi-task learning framework that is specifically designed to jointly predict both the appropriate drug recommendations and the associated evidential paths or components from the MKG. Additionally, the authors developed a systematic framework for automatically constructing patient health records to generate a diverse and extensive dataset, forming the DrugRec testbed.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The paper's core contribution is the conceptualization and development of TraceDR, a system that successfully enables traceability for drug recommendations by explicitly linking them to evidence within an MKG. This framework allows for the coverage of a significantly more diverse set of diseases and drugs than previously possible. Furthermore, the creation and release of DrugRec serves as a substantial new resource for the drug recommendation research community.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>TraceDR has the potential to significantly enhance the clinical utility and adoption of AI-powered drug recommendation systems by providing transparency. This leads to increased clinician trust, improved patient safety by enabling validation of recommendations, and better-informed clinical decision-making, particularly in complex cases or for novel therapies. It moves AI from a 'black box' tool to a collaborative decision-support system.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not detail specific empirical performance metrics (e.g., accuracy, precision, recall) or comparative evaluations of TraceDR against existing state-of-the-art methods. It also does not discuss potential computational overhead, scalability challenges in real-world deployment, or explicit ethical considerations beyond the benefit of traceability itself.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated as 'future directions' in the abstract, the release of DrugRec as a new large-scale testbed inherently implies future research opportunities for validating, refining, and extending drug recommendation models. Further work would likely involve rigorous empirical evaluation of TraceDR's performance, exploration of different MKG construction methods, and integration with real-world clinical workflows.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Clinical Pharmacology</span>
                    
                    <span class="tag">Medical Informatics</span>
                    
                    <span class="tag">Artificial Intelligence in Medicine</span>
                    
                    <span class="tag">Clinical Decision Support Systems</span>
                    
                    <span class="tag">Patient Safety</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug Recommendation</span>
                    
                    <span class="tag tag-keyword">Medical Knowledge Graph</span>
                    
                    <span class="tag tag-keyword">Traceability</span>
                    
                    <span class="tag tag-keyword">Explainable AI</span>
                    
                    <span class="tag tag-keyword">Multi-task Learning</span>
                    
                    <span class="tag tag-keyword">Clinical Decision Support</span>
                    
                    <span class="tag tag-keyword">Patient Safety</span>
                    
                    <span class="tag tag-keyword">Healthcare AI</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Drug recommendation (DR) systems aim to support healthcare professionals in
selecting appropriate medications based on patients' medical conditions.
State-of-the-art approaches utilize deep learning techniques for improving DR,
but fall short in providing any insights on the derivation process of
recommendations -- a critical limitation in such high-stake applications. We
propose TraceDR, a novel DR system operating over a medical knowledge graph
(MKG), which ensures access to large-scale and high-quality information.
TraceDR simultaneously predicts drug recommendations and related evidence
within a multi-task learning framework, enabling traceability of medication
recommendations. For covering a more diverse set of diseases and drugs than
existing works, we devise a framework for automatically constructing patient
health records and release DrugRec, a new large-scale testbed for DR.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted to MediKS@CIKM2025</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>